Brief: Cytosorbents Updates U.S. FDA Regulatory Status Of Drugsorb-Atr

Cytosorbents

20/08/2025 13:22

Aug 20 (Reuters) - Cytosorbents Corp CTSO.O:

CYTOSORBENTS UPDATES U.S. FDA REGULATORY STATUS OF DRUGSORB-ATR

CYTOSORBENTS CORP - FDA FINDS NO SAFETY ISSUES WITH DRUGSORB-ATR, UPHOLDS DENIAL

CYTOSORBENTS CORP - FDA PROPOSES PATH FORWARD FOR DRUGSORB-ATR MARKET AUTHORIZATION

CYTOSORBENTS CORP - FDA NOTES APPEAL AVENUE TO CDRH DIRECTOR WITHIN 30 DAYS

Source text: ID:nPn5ktnsta

Further company coverage: CTSO.O

 ((Reuters.Briefs@thomsonreuters.com;))